VEGFA and hepatocellular carcinoma: Intriguingly, losartan also attenuated the lenvatinib-mediated VEGF-A production in three types of HCC cell lines, suggesting that combination with losartan may help prevent HCC cells from acquiring resistance to lenvatinib.